Charles River Laboratories International Inc
Charles River Laboratories International Inc (CRL) Option Chain
Read more
Tracking the CRL option chain helps you see every strike and expiry on Charles River Laboratories International Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CRL options activity at a glance. Use our scanner to monitor the CRL option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CRL stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where CRL options are being actively traded, and where they are not.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 111 | 1 | 14.65 | 23.60 | 36.20 | 40.30 | 290.00 | -11.57 | — | 4.00 | 0.00 | 4.00 | 0 | 162 | 100.00 |
| 0.01 | 242 | 0 | 14.65 | 13.60 | 26.40 | 30.10 | 300.00 | -8.52 | — | 2.65 | 0.00 | 2.65 | 0 | 284 | 99.99 |
| 0.76 | 89 | 0 | 15.00 | 3.60 | 16.90 | 20.30 | 310.00 | -5.47 | — | 2.70 | 0.00 | 2.70 | 0 | 945 | 99.24 |
| 14.65 | 133 | 4 | 9.50 | 0.00 | 7.70 | 11.30 | 320.00 | -2.42 | — | 4.90 | 6.40 | -1.50 | 0 | 89 | 85.35 |
| 61.04 | 71 | 3 | 3.33 | 0.00 | 1.85 | 4.80 | 330.00 | +0.63 | 3.40 | 6.40 | 16.40 | -11.50 | 12 | 620 | 38.96 |
As of Nov 19, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryDiagnostics & Research
- SectorHealthcare
- IV Rank53.97% Moderate
- Market cap (M$)15,714
- 52 weeks high-13.62%
- 52 weeks low124.30%
- Analyst recommendationBuy
1.85 - Target price$368.07
17.37% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2027-02-17
- P/E363.48
- Future P/E25.37
- EPS (ttm)0.90
- EPS growth next 5 years12.17%
As of Nov 19, 2026